Pro- and Anti-Inflammatory Cytokine Balance in Major Depression: Effect of Sertraline Therapy
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
The specific associations between antidepressant treatment and alterations in the levels of cytokines remain to be elucidated. In this study, we aimed to explore the role of IL-2, IL-4, IL-12, TNF-α, TGF-β1, and MCP-1 in major depression and to investigate the effects of sertraline therapy. Cytokine and chemokine levels were measured at the time of admission and 8 weeks after sertraline treatment. Our results suggest that the proinflammatory cytokines (IL-2, IL-12, and TNF-α) and MCP-1 were significantly higher, whereas anti-inflammatory cytokines IL-4 and TGF-β1 were significantly lower in patients with major depression than those of healthy controls. It seems likely that the sertraline therapy might have exerted immunomodulatory effects through a decrease in the proinflammatory cytokine IL-12 and an increase in the anti-inflammatory cytokines IL-4 and TGF-β1. In conclusion, our results indicate that Th1-, Th2-, and Th3-type cytokines are altered in the depressed patients and some of them might have been corrected by sertraline treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Fluoxetine, paroxetine, venlafaxine, and sertraline have been shown to have the potential to increase the levels of TGF-β1, which may contribute to their antidepressant effects. 391 , 392”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [392]
Experimental — accuracy not yet measuredIn the citing paper
“Sutcigil et al. found elevated serum levels of IL-12, which decreased after eight weeks of sertraline therapy [120].”
From Selected biomarkers of depression: what are the effects of cytokines and inflammation (2022) · cites this paper as [120]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Delves, P. J., & Roitt, I. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007063430107 · Cited by 1,666
Evidence for an immune response in major depression: A review and hypothesis
Maes, M. (1995) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)00101-m · Cited by 1,003
Cytokine Production and Treatment Response in Major Depressive Disorder
Lanquillon, S. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00134-7 · Cited by 735
Maes, M., Meltzer, H. Y., Bosmans, E., Bergmans, R., Vandoolaeghe, E., Ranjan, R., & Desnyder, R. (1995) · Journal of Affective Disorders · doi:10.1016/0165-0327(95)00028-l · Cited by 622
Depression, stress and immunological activation: The role of cytokines in depressive disorders
Connor, T. J., & Leonard, B. E. (1998) · Life Sciences · doi:10.1016/s0024-3205(97)00990-9 · Cited by 482
Tuglu, C., Kara, S. H., Caliyurt, O., Vardar, E., & Abay, E. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1566-z · Cited by 391
Licinio, J., & Wong, M.-L. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000586 · Cited by 380
Th1, Th2, and Th3 cytokine alterations in major depression
MYINT, A., LEONARD, B., STEINBUSCH, H., & KIM, Y. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.07.008 · Cited by 371
Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression?
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.8.1189 · Cited by 364
Kubera, M., Lin, A.-H., Kenis, G., Bosmans, E., van Bockstaele, D., & Maes, M. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200104000-00012 · Cited by 343
Cited by
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Goldsmith, D. R., Rapaport, M. H., & Miller, B. J. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.3 · Cited by 1,683
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Cui, L., Li, S., Wang, S., Wu, X., Liu, Y., Yu, W., Wang, Y., Tang, Y., Xia, M., & Li, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01738-y · Cited by 1,244
“391,392 Venlafaxine has also been reported to exert neuroprotection by increasing the production of FGF-2 and TGF-β 1 in astrocytes following stroke.”
BackgroundImmune system to brain signaling: Neuropsychopharmacological implications
Capuron, L., & Miller, A. H. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.014 · Cited by 1,195
Haapakoski, R., Mathieu, J., Ebmeier, K. P., Alenius, H., & Kivimäki, M. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.06.001 · Cited by 1,129
“, 2010), 31 studies for TNF-a (Dahl et al., 2014; Diniz et al., 2010b; Dome et al., 2009; Dunjic-Kostic et al., 2013; Eller et al., 2009, 2008; Euteneuer et al., 2011; Fitzgerald et al., 2006; Fornaro et al., 2013; Grassi-Oliveira et al., 2009; Hornig et al., 1998; Huang and Lee, 2007; Hughes et al., 2012; Kagaya et a…”
Haroon, E., Raison, C. L., & Miller, A. H. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.205 · Cited by 1,000
“Reduced IL-10 and TGF-b, as well as an increased IL-6/IL-10 ratio, have been found in depressed patients and are believed to be consistent with reduced T reg expression and/or function (Sutcigil et al, 2007; Dhabhar et al, 2009).”
BackgroundLiu, Y., Ho, R. C.-M., & Mak, A. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.08.003 · Cited by 948
Osimo, E. F., Pillinger, T., Rodriguez, I. M., Khandaker, G. M., Pariante, C. M., & Howes, O. D. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.02.010 · Cited by 937
“…al., 2013; Piletz et al., 2009; Pike and Irwin, 2006; Pavón et al., 2006; Owen et al., 2001; Ogłodek, 2018; Tuglu et al., 2003; Thomas et al., 2005; Sutcigil et al., 2008; SowaKućma et al., 2018; Sluzewska et al., 1996; Simon et al., 2008; Seidel et al., 1995; Schlatter et al., 2004; Savitz et…”
The vascular depression hypothesis: mechanisms linking vascular disease with depression
Taylor, W. D., Aizenstein, H. J., & Alexopoulos, G. S. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.20 · Cited by 923
Hannestad, J., DellaGioia, N., & Bloch, M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.132 · Cited by 914
Leonard, B., & Maes, M. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.12.005 · Cited by 805
Maes, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.06.014 · Cited by 544
Moylan, S., Maes, M., Wray, N. R., & Berk, M. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.33 · Cited by 529
Functional Biomarkers of Depression: Diagnosis, Treatment, and Pathophysiology
Schmidt, H. D., Shelton, R. C., & Duman, R. S. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.151 · Cited by 474
Liu, J. J., Wei, Y. B., Strawbridge, R., Bao, Y., Chang, S., Shi, L., Que, J., Gadad, B. S., Trivedi, M. H., Kelsoe, J. R., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0474-5 · Cited by 429
Dahl, J., Ormstad, H., Aass, H. C. D., Malt, U. F., Bendz, L. T., Sandvik, L., Brundin, L., & Andreassen, O. A. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.03.019 · Cited by 424
Immune and neuroendocrine mechanisms of stress vulnerability and resilience
Ménard, C., Pfau, M. L., Hodes, G. E., & Russo, S. J. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.90 · Cited by 374
Beyond a neurotransmitter: The role of serotonin in inflammation and immunity
Wu, H., Denna, T. H., Storkersen, J. N., & Gerriets, V. A. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2018.06.015 · Cited by 338
Omega-3 fatty acids and depression: scientific evidence and biological mechanisms
Grosso, G., Galvano, F., Marventano, S., Malaguarnera, M., Bucolo, C., Drago, F., & Caraci, F. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/313570 · Cited by 351
Khairova, R. A., Machado-Vieira, R., Du, J., & Manji, H. K. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709009924 · Cited by 350
Depression and Alzheimer's disease: Neurobiological links and common pharmacological targets
Caraci, F., Copani, A., Nicoletti, F., & Drago, F. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.10.022 · Cited by 314
You, Z., Luo, C., Zhang, W., Chen, Y., He, J., Zhao, Q., Zuo, R., & Wu, Y. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.07.006 · Cited by 299
Selected biomarkers of depression: what are the effects of cytokines and inflammation
Harsanyi, S., Kupcova, I., Danisovic, L., & Klein, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010578 · Cited by 299
Leighton, S. P., Nerurkar, L., Krishnadas, R., Johnman, C., Graham, G. J., & Cavanagh, J. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.205 · Cited by 291
Stuart, M. J., & Baune, B. T. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.02.001 · Cited by 259
Evidence for a Dysregulated Immune System in the Etiology of Psychiatric Disorders
Gibney, S. M., & Drexhage, H. A. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9462-8 · Cited by 234
A psychoneuroimmunological review on cytokines involved in antidepressant treatment response
Janssen, D. G. A., Caniato, R. N., Verster, J. C., & Baune, B. T. (2010) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1103 · Cited by 240
“(2007) also found increased IL-12 in depressed patients, which reduced after treatment with fluoxetine, venlafaxine, or paroxetine (Lee and Kim, 2006) or sertraline (Sutcigil et al., 2007).”
BackgroundInfluentialEffect of antidepressant treatment on peripheral inflammation markers – A meta-analysis
Więdłocha, M., Marcinowicz, P., Krupa, R., Janoska-Jaździk, M., Janus, M., Dębowska, W., Mosiołek, A., Waszkiewicz, N., & Szulc, A. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.026 · Cited by 233
Dhabhar, F. S., Burke, H. M., Epel, E. S., Mellon, S. H., Rosser, R., Reus, V. I., & Wolkowitz, O. M. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.05.010 · Cited by 225
“However, findings similar to ours have been reported by a study showing that patients with major depression express significantly higher circulating concentrations of pro-inflammatory cytokines and significantly lower concentrations of anti-inflammatory cytokines and that these differences are reversed following serta…”
BackgroundResultZou, W., Feng, R., & Yang, Y. (2018) · PLOS ONE · doi:10.1371/journal.pone.0197267 · Cited by 224
Inflammatory markers in depression
Dinan, T. G. (2009) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328315a561 · Cited by 205
Chen, Y., Jiang, T., Chen, P., Ouyang, J., Xu, G., Zeng, Z., & Sun, Y. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2010.10.029 · Cited by 209
Role of serotonin receptor signaling in cancer cells and anti-tumor immunity
Karmakar, S., & Lal, G. (2021) · Theranostics · doi:10.7150/thno.55986 · Cited by 196
Wang, L., Wang, R., Liu, L., Qiao, D., Baldwin, D. S., & Hou, R. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.02.021 · Cited by 185
A meta-analysis of chemokines in major depression
Eyre, H. A., Air, T., Pradhan, A., Johnston, J., Lavretsky, H., Stuart, M. J., & Baune, B. T. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.02.006 · Cited by 188
A critical review of human endotoxin administration as an experimental paradigm of depression.
DellaGioia, N., & Hannestad, J. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.07.014 · Cited by 175
“…12.63 6.71 19.83 9.7 13.87 14.5 62 depressed 35 remitted O’Brien et al. (2007) 24 control 10.88 1.31 19.64 2.44 10.77 2.18 28 depressed 16 remitted Sutcigil et al. (2007) 25 control 36.04 12.63 77.68 16.21 26 depressed Tuglu et al. (2003) 17 control 5.19 1.18 9.08 3.23 30 depressed Yang et al.…”
BackgroundInfluentialCaraci, F., Spampinato, S. F., Morgese, M. G., Tascedda, F., Salluzzo, M. G., Giambirtone, M. C., Caruso, G., Munafò, A., Torrisi, S. A., Leggio, G. M., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.02.007 · Cited by 172
Astrocytes and the TGF-β1 Pathway in the Healthy and Diseased Brain: a Double-Edged Sword
Diniz, L. P., Matias, I., Siqueira, M., Stipursky, J., & Gomes, F. C. A. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1396-y · Cited by 159
Raison, C. L., Lowry, C. A., & Rook, G. A. W. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.161 · Cited by 169
“Given these alterations, it is not surprising that when compared with nondepressed individuals, both medically ill and medically healthy patients with MDD have been found to exhibit all of the cardinal features of inflammation, as well as reduced plasma/serum concentrations of the immunoregulatory, anti-inflammatory c…”
Therapeutic Strategies for Treatment of Inflammation-related Depression
Adzic, M., Brkic, Z., Mitic, M., Francija, E., Jovicic, M. J., Radulovic, J., & Maric, N. P. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666170828163048 · Cited by 156
The effects of vitamin B on the immune/cytokine network and their involvement in depression
Mikkelsen, K., Stojanovska, L., Prakash, M. D., & Apostolopoulos, V. (2016) · Maturitas · doi:10.1016/j.maturitas.2016.11.012 · Cited by 168
Treating Depression and Depression-Like Behavior with Physical Activity: An Immune Perspective
Eyre, H. A., Papps, E., & Baune, B. T. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00003 · Cited by 146
Al-Hakeim, H. K., Al-Rammahi, D. A., & Al-Dujaili, A. H. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.04.044 · Cited by 152
Therapeutic Implications of Brain–Immune Interactions: Treatment in Translation
Miller, A. H., Haroon, E., & Felger, J. C. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.167 · Cited by 152
Goldsmith, D. R., Haroon, E., Woolwine, B. J., Jung, M. Y., Wommack, E. C., Harvey, P. D., Treadway, M. T., Felger, J. C., & Miller, A. H. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.03.025 · Cited by 140
The Role of Chemokines in the Pathophysiology of Major Depressive Disorder
Milenkovic, V. M., Stanton, E. H., Nothdurfter, C., Rupprecht, R., & Wetzel, C. H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092283 · Cited by 144
Comorbidity between depression and asthma via immune-inflammatory pathways: a meta-analysis
Jiang, M., Qin, P., & Yang, X. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.04.027 · Cited by 146
Dionisie, V., Filip, G. A., Manea, M. C., Manea, M., & Riga, S. (2020) · Inflammopharmacology · doi:10.1007/s10787-020-00777-5 · Cited by 181
Byrne, M. L., O’Brien-Simpson, N. M., Reynolds, E. C., Walsh, K. A., Laughton, K., Waloszek, J. M., Woods, M. J., Trinder, J., & Allen, N. B. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.08.010 · Cited by 144
Caraci, F., Battaglia, G., Bruno, V., Bosco, P., Carbonaro, V., Giuffrida, M. L., Drago, F., Sortino, M. A., Nicoletti, F., & Copani, A. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2009.00115.x · Cited by 135
The importance of cytokines and autoantibodies in depression
Postal, M., & Appenzeller, S. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.09.001 · Cited by 153
Molecular aspects of depression: A review from neurobiology to treatment
Villas Boas, G. R., Boerngen de Lacerda, R., Paes, M. M., Gubert, P., Almeida, W. L. D. C., Rescia, V. C., de Carvalho, P. M. G., de Carvalho, A. A. V., & Oesterreich, S. A. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.02.024 · Cited by 128
Wood, S. K., Wood, C. S., Lombard, C. M., Lee, C. S., Zhang, X.-Y., Finnell, J. E., & Valentino, R. J. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.10.026 · Cited by 131
The role of TGF-β superfamily signaling in neurological disorders
Kashima, R., & Hata, A. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmx124 · Cited by 126
Abnormalities in serum chemokine levels in euthymic patients with Bipolar Disorder
Brietzke, E. M., Kauer‐Sant’Anna, M., Teixeira, A. L., & Kapczinski, F. P. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.04.008 · Cited by 143
Musil, R., Schwarz, M., Riedel, M. J., Dehning, S., Cerovecki, A., Spellmann, I., Arolt, V., & Müller, N. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.05.047 · Cited by 131
The putative neurodegenerative links between depression and Alzheimer's disease
Wuwongse, S., Chang, R. C., & Law, A. C. K. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.005 · Cited by 133
Davami, M., Baharlou, R., Ahmadi Vasmehjani, A., Ghanizadeh, A., Keshtkar, M., Dezhkam, I., & Atashzar, M. (2016) · Basic and Clinical Neuroscience Journal · doi:10.15412/j.bcn.03070207 · Cited by 124
“However, other reported that the level of TGF-β was decreased in patients with depression than the healthy controls (Musil et al., 2011; Sutcigil et al., 2007).”
BackgroundCarniel, B. P., & da Rocha, N. S. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110151 · Cited by 127
Diniz, L. P., Tortelli, V., Garcia, M. N., Araújo, A. P. B., Melo, H. M., Seixas da Silva, G. S., De Felice, F. G., Alves‐Leon, S. V., de Souza, J. M., Romão, L. F., et al. (2014) · Glia · doi:10.1002/glia.22713 · Cited by 116
Dysfunction of TGF-β1 signaling in Alzheimer’s disease: perspectives for neuroprotection
Caraci, F., Spampinato, S. F., Sortino, M. A., Bosco, P., Battaglia, G., Bruno, V., Drago, F., Nicoletti, F., & Copani, A. (2011) · Cell and Tissue Research · doi:10.1007/s00441-011-1230-6 · Cited by 118
Growth factors as clinical biomarkers of prognosis and diagnosis in psychiatric disorders
Galvez-Contreras, A. Y., Campos-Ordonez, T., Lopez-Virgen, V., Gomez-Plascencia, J., Ramos-Zuniga, R., & Gonzalez-Perez, O. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.08.004 · Cited by 112
Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?
Cardamone, L., Salzberg, M., O'Brien, T. J., & Jones, N. C. (2012) · British Journal of Pharmacology · doi:10.1111/bph.12052 · Cited by 118
Sadeghi, H., Hajhashemi, V., Minaiyan, M., Movahedian, A., & Talebi, A. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.05.053 · Cited by 122
Kim, Y.-K., Kim, O. Y., & Song, J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01270 · Cited by 109
“Moreover, higher concentrations of several chemokines, such as CCL2 and CXCL8, were detected in the serum and CSF of depressed patients (Sutcigil et al., 2007; Piletz et al., 2009; Black and Miller, 2015; Khandaker et al., 2015; Slusarczyk et al., 2016).”
BackgroundMedina-Rodriguez, E. M., Lowell, J. A., Worthen, R. J., Syed, S. A., & Beurel, E. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00547 · Cited by 101
Inflammation: a mechanism of depression?
Han, Q.-Q., & Yu, J. M. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1439-3 · Cited by 118
Egeberg, A., Hansen, P. R., Gislason, G., & Thyssen, J. P. (2016) · Dermatology · doi:10.1159/000444082 · Cited by 105
Psychosocial Burden and Other Impacts of Rosacea on Patients’ Quality of Life
Oussedik, E., Bourcier, M., & Tan, J. K. L. (2017) · Dermatologic Clinics · doi:10.1016/j.det.2017.11.005 · Cited by 109
Haimovici, F., Anderson, J. L., Bates, G. W., Racowsky, C., Ginsburg, E. S., Simovici, D., & Fichorova, R. N. (2018) · American Journal of Reproductive Immunology · doi:10.1111/aji.12832 · Cited by 101
Hong, M., Zheng, J., Ding, Z.-Y., Chen, J.-H., Yu, L., Niu, Y., Hua, Y.-Q., & Wang, L.-L. (2013) · Neuroimmunomodulation · doi:10.1159/000343100 · Cited by 100
Review: Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment
Haussleiter, I. S., Brüne, M., & Juckel, G. (2009) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285608100325 · Cited by 93
Serum chemokine levels in major depressive disorder
Lehto, S. M., Niskanen, L., Herzig, K.-H., Tolmunen, T., Huotari, A., Viinamäki, H., Koivumaa-Honkanen, H., Honkalampi, K., Ruotsalainen, H., & Hintikka, J. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.06.007 · Cited by 100
Applications of blood-based protein biomarker strategies in the study of psychiatric disorders
Chan, M. K., Gottschalk, M. G., Haenisch, F., Tomasik, J., Ruland, T., Rahmoune, H., Guest, P. C., & Bahn, S. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.08.002 · Cited by 101
Research Review: The role of cytokines in depression in adolescents: a systematic review
Mills, N. T., Scott, J. G., Wray, N. R., Cohen‐Woods, S., & Baune, B. T. (2013) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12080 · Cited by 92
Robson, M. J., Quinlan, M. A., & Blakely, R. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00412 · Cited by 104
Taraz, M., Taraz, S., & Dashti‐Khavidaki, S. (2014) · Hemodialysis International · doi:10.1111/hdi.12200 · Cited by 102
The cytokine network in the pathogenesis of major depressive disorder. Close to translation?
Petralia, M. C., Mazzon, E., Fagone, P., Basile, M. S., Lenzo, V., Quattropani, M. C., Di Nuovo, S., Bendtzen, K., & Nicoletti, F. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102504 · Cited by 84
Stress-Related Immune Markers in Depression: Implications for Treatment
Hughes, M. M., Connor, T. J., & Harkin, A. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw001 · Cited by 85
Metabotropic glutamate receptors in the tripartite synapse as a target for new psychotropic drugs
Wierońska, J. M., & Pilc, A. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.02.019 · Cited by 95
Dean, B. (2011) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001410 · Cited by 88
Torrisi, S. A., Geraci, F., Tropea, M. R., Grasso, M., Caruso, G., Fidilio, A., Musso, N., Sanfilippo, G., Tascedda, F., Palmeri, A., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00693 · Cited by 86
Taraz, M., Khatami, M., Dashti‐Khavidaki, S., Akhondzadeh, S., Noorbala, A.-A., Ghaeli, P., & Taraz, S. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.09.020 · Cited by 94
Carboni, L., Becchi, S., Piubelli, C., Mallei, A., Giambelli, R., Razzoli, M., Mathé, A. A., Popoli, M., & Domenici, E. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.05.019 · Cited by 92
Borsini, A., Di Benedetto, M. G., Giacobbe, J., & Pariante, C. M. (2020) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa055 · Cited by 88
The role of the neuroendocrine and immune systems in the pathogenesis of depression
Ogłodek, E., Szota, A. M., Just, M. J., Moś, D., & Araszkiewicz, A. S. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.04.009 · Cited by 97
CSF biomarkers in suicide attempters – a principal component analysis
Lindqvist, D., Janelidze, S., Erhardt, S., Träskman‐Bendz, L., Engström, G., & Brundin, L. (2011) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01655.x · Cited by 86
Rush, G., O’Donovan, A., Nagle, L., Conway, C., McCrohan, A., O’Farrelly, C., Lucey, J. V., & Malone, K. M. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.06.035 · Cited by 86
Değer, S. M., Öztürk, M. A., Demirağ, M. D., Aslan, S., Göker, B., Haznedaroğlu, Ş., & Onat, A. M. (2010) · Rheumatology International · doi:10.1007/s00296-009-1334-4 · Cited by 88
Antidepressant Compounds Can Be Both Pro- and Anti-Inflammatory in Human Hippocampal Cells
Horowitz, M. A., Wertz, J., Zhu, D., Cattaneo, A., Musaelyan, K., Nikkheslat, N., Thuret, S., Pariante, C. M., & Zunszain, P. A. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu076 · Cited by 79
Modulatory Effects of Antidepressant Classes on the Innate and Adaptive Immune System in Depression
Eyre, H., Lavretsky, H., Kartika, J., Qassim, A., & Baune, B. (2016) · Pharmacopsychiatry · doi:10.1055/s-0042-103159 · Cited by 73
Depression and Cardiovascular Disease: The Viewpoint of Platelets
Amadio, P., Zarà, M., Sandrini, L., Ieraci, A., & Barbieri, S. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207560 · Cited by 82
Pathobiological targets of depression
Chopra, K., Kumar, B., & Kuhad, A. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.553603 · Cited by 76
Casaril, A. M., Domingues, M., Fronza, M. G., Vieira, B. M., Begnini, K. R., Lenardao, E. J., Seixas, F. K., Collares, T. V., Nogueira, C. W., & Savegnago, L. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117711713 · Cited by 77
Anti-inflammatory properties of commonly used psychiatric drugs
Patel, S., Keating, B. A., & Dale, R. C. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1039379 · Cited by 78
Aquatic blues: Modeling depression and antidepressant action in zebrafish
Nguyen, M., Stewart, A., & Kalueff, A. V. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.03.003 · Cited by 77
Oh, J., & Kim, T. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.02.002 · Cited by 76
Lehto, S. M., Niskanen, L., Tolmunen, T., Hintikka, J., Viinamäki, H., Heiskanen, T., Honkalampi, K., Kokkonen, M., & Koivumaa‐Honkanen, H. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2010.02079.x · Cited by 72
Finnell, J. E., & Wood, S. K. (2016) · Neurobiology of Stress · doi:10.1016/j.ynstr.2016.04.001 · Cited by 67
Serum cytokines and anxiety in adolescent depression patients: Gender effect
Pallavi, P., Sagar, R., Mehta, M., Sharma, S., Subramanian, A., Shamshi, F., Sengupta, U., Pandey, R. M., & Mukhopadhyay, A. K. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.06.036 · Cited by 74
Metadata
- Authors
- Sutcigil, L., Oktenli, C., Musabak, U., Bozkurt, A., Cansever, A., Uzun, O., Sanisoglu, S. Y., Yesilova, Z., Ozmenler, N., Ozsahin, A., & Sengul, A.
- Affiliations
- Gülhane Askerî Tıp Akademisi (TR)
- Venue
- Clinical and Developmental Immunology
- Publisher
- Hindawi Limited
- Published
- 2007
- Volume
- 2007
- Pages
- 1-6
- ISSN
- 1740-2522 (ISSN-L)
- 1740-2530
- PMC
- PMC2248234
- OpenAlex
- W1998520631
- Cited by
- 315
- References
- 36
- Citations by year
- 2026: 2 · 2025: 15 · 2024: 19 · 2023: 13 · 2022: 9 · 2021: 26 · 2020: 24 · 2019: 16 · 2018: 14 · 2017: 21 · 2016: 28 · 2015: 11 · 2014: 28 · 2013: 17 · 2012: 16
- FWCI
- 4.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Clinical and Developmental Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- AYBU AVESIS (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Gülhane Military Medical Academy
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- major depressive disorder, sertraline, cytokines, chemokines, inflammatory cytokines, anti-inflammatory cytokines, IL-12, IL-4, TNF-α, TGF-β1, MCP-1, immunomodulation, antidepressant effects, Th1/Th2 balance
- MeSH terms
- Adult, Antidepressive Agents, Major Depressive Disorder, Depressive Disorder, Major, Enzyme-Linked Immunosorbent Assay, Female, Humans, Interleukin-2, Male, Tumor Necrosis Factor-alpha, Interleukin-4, Cytokines, Interleukin-12, Chemokine CCL2, Sertraline, Transforming Growth Factor beta1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.